MarketPeel
Insider Trading Intelligence
Pricing
…
LN

Laura E. Niklason

HUMA
PRESIDENT, CEO AND DIRECTOR · HUMACYTE, INC. · CIK 0001878075
FILING MIX · LIFETIME47%/53%
BUYS
32
SELLS
36
TOTAL VALUE
$91.15M
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
80,000
AVG SELL PX
$3.55
TRADE KIND
SHOWING 68 / 68
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
13 backtested trades · 8 horizons · 11 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Laura E. Niklason, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d13+100.00%-8.07%+0.67%-8.74%-10.47%—
14d13+84.62%-9.45%+1.63%-11.09%-11.31%—
30d13+69.23%-14.58%+1.83%-16.41%-17.47%—
60d13+61.54%-14.72%+1.73%-16.44%-19.50%—
90d13+92.31%-29.79%+1.89%-31.68%-30.24%—
180d13+92.31%-47.38%-1.95%-45.43%-43.23%—
1y13(3 pending)+90.00%-66.74%+3.93%-70.67%-74.08%—
2y13(8 pending)+100.00%-40.24%+11.04%-51.28%-68.70%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HUMA · 80,000 shares · as of Jun 11, 2026
05,113,12610,226,25215,339,37820,452,50420222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 32 buys / 36 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
80,000——80,000Jun 11, 2026Jun 12, 2026 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
311,100——311,100Nov 16, 2025Nov 17, 2025 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
591,685$1.58$934.9K0Aug 20, 2025Aug 20, 2025 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
1,100,000$1.63$1.79M591,685Aug 19, 2025Aug 20, 2025 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
549,360$1.83$1.01M1,691,685Aug 18, 2025Aug 20, 2025 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
0——0Jun 12, 2025Jun 16, 2025 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
1,130,311——1,130,311Jan 21, 2025Jan 23, 2025 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
525——2,625Dec 19, 2024Dec 20, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
261,369$4.40$1.15M1,730,884Nov 20, 2024Nov 20, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
427,459$4.34$1.86M1,992,253Nov 19, 2024Nov 20, 2024 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
President, CEO and Director
1,797$4.44$8.0K243,851Nov 19, 2024Nov 21, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
811,172$4.44$3.60M2,419,712Nov 18, 2024Nov 20, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
288,674$5.23$1.51M3,230,884Sep 10, 2024Sep 11, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
157,704$5.42$854.8K3,519,558Sep 9, 2024Sep 11, 2024 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
President, CEO and Director
1,222$6.55$8.0K242,054Aug 29, 2024Sep 3, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
352,112$6.35$2.24M3,677,262Aug 29, 2024Aug 29, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
277,090$6.47$1.79M4,029,374Aug 28, 2024Aug 29, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
252,676$6.71$1.70M4,306,464Aug 27, 2024Aug 29, 2024 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
50,000——50,000Jun 13, 2024Jun 17, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
271,518$7.30$1.98M4,559,140Jun 12, 2024Jun 13, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
282,000$7.09$2.00M4,907,288Jun 11, 2024Jun 13, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
76,630$7.02$537.9K4,830,658Jun 11, 2024Jun 13, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
1,852$7.28$13.5K5,189,288Jun 4, 2024Jun 4, 2024 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
President, CEO and Director
2,362$6.35$15.0K240,832Jun 4, 2024Jun 4, 2024 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
President, CEO and Director
2,050$7.37$15.1K238,470Jun 3, 2024Jun 3, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
190,214$7.42$1.41M5,191,140Jun 3, 2024Jun 4, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
716,573$7.78$5.57M5,474,567May 31, 2024Jun 4, 2024 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
93,213$8.93$832.4K5,381,354May 31, 2024Jun 4, 2024 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
525——2,100Dec 11, 2023Dec 12, 2023 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
803,000——803,000Dec 8, 2023Dec 12, 2023 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
114,420——48,176Oct 10, 2023Oct 10, 2023 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
President, CEO and Director
114,420$1.19$136.2K1,384,660Oct 10, 2023Oct 10, 2023 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
2,000,000$2.78$5.56M6,191,140Sep 14, 2023Sep 15, 2023 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
602,443$3.39$2.04M8,191,140Aug 21, 2023Aug 21, 2023 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
626,979$3.57$2.24M8,793,583Aug 18, 2023Aug 21, 2023 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
570,174$3.68$2.10M9,420,562Aug 17, 2023Aug 21, 2023 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
500,000$3.12$1.56M9,990,736Jun 15, 2023Jun 16, 2023 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
8,500——8,500Jun 15, 2023Jun 16, 2023 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
4,875,000$2.60$12.68M10,490,736Jun 13, 2023Jun 15, 2023 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
2,625,000$2.75$7.22M15,365,736May 25, 2023May 26, 2023 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
President, CEO and Director
100,000$1.19$119.0K1,270,240Mar 1, 2023Mar 2, 2023 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
100,000——162,596Mar 1, 2023Mar 2, 2023 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
239,538$2.53$606.0K17,990,736Dec 16, 2022Dec 19, 2022 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
93,426$2.63$245.7K18,230,274Dec 15, 2022Dec 15, 2022 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
President, CEO and Director
10,000$2.54$25.4K1,170,240Dec 15, 2022Dec 19, 2022 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
276,304$2.76$762.6K18,323,700Dec 14, 2022Dec 15, 2022 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
330,000$2.84$937.2K18,600,004Dec 13, 2022Dec 15, 2022 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
444,500——444,500Dec 8, 2022Dec 12, 2022 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
1,522,500$4.00$6.09M18,930,004Sep 15, 2022Sep 19, 2022 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
President, CEO and Director
2,000$4.14$8.3K1,160,240Sep 15, 2022Sep 19, 2022 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
8,500——8,500Jun 9, 2022Jun 13, 2022 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
President, CEO and Director
10,000$4.83$48.3K1,158,240May 23, 2022May 25, 2022 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
75,000$9.00$675.0K510,161Dec 16, 2021Dec 16, 2021 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
125,000$8.89$1.11M585,161Dec 15, 2021Dec 16, 2021 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
76,306$9.33$711.6K710,161Dec 14, 2021Dec 16, 2021 ↗View →
HUMA
HUMACYTE, INC.
SALE
President, CEO and Director
23,694$9.80$232.2K786,467Dec 14, 2021Dec 16, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
8,500——8,500Oct 13, 2021Oct 15, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASE
President, CEO and Director
1,522,500$10.00$15.22M20,452,504Aug 26, 2021Aug 27, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
13,129——13,129Aug 26, 2021Aug 27, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
13,129——13,129Aug 26, 2021Aug 27, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
1,148,240——1,148,240Aug 26, 2021Aug 27, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
17,068——17,068Aug 26, 2021Aug 27, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
18,930,004——18,930,004Aug 26, 2021Aug 27, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
262,596——262,596Aug 26, 2021Aug 27, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
1,312,984——1,312,984Aug 26, 2021Aug 27, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
157,558——157,558Aug 26, 2021Aug 27, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
131,298——131,298Aug 26, 2021Aug 27, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
1,575——1,575Aug 26, 2021Aug 27, 2021 ↗View →
Other insiders · HUMA
Loading peer insiders…
About this filer
CIK 0001878075
ROLE
President, CEO and Director
PRIMARY
HUMA
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001878075DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback